Effects of Lateral Femoral Cutaneous Nerve Mobilization With and Without Muscle Energy Techniques in Pregnant Females

Not Applicable

Completed

• Conditions: Meralgia Paresthetica

• Registration Number: NCT06751147
• Lead Sponsor: Riphah International University

Brief Summary

The rationale of this study is to provide empirical evidence regarding the efficacy and safety of neural mobilization in pregnant women with meralgia paresthetica. By investigating the potential benefits of this intervention, healthcare professionals can make informed decisions about incorporating neural mobilization into the management of this condition during pregnancy. Focusing on the impact of neural mobilization and muscle energy techniques on both neuropathic pain and quality of life aligns with a patient-centered approach to care. The goal is not only to reduce symptoms but also to enhance overall well-being and functional capacity

Detailed Description

The literature gap of the study is that upto our knowledge, there is little or no evidence found in previous researches on the combined effects of lateral femoral cutaneous nerve mobilization in combination with MET in pregnant females. Secondly no quantitative measurement as range of motion with goniometer has been yet studied

Study Timeline

• Study First Submitted: 2024-12-20
• Study First Submitted QC: 2024-12-20
• Study Start: 2024-12-23
• Study First Posted: 2024-12-27
• Primary Completion: 2025-05-15
• Study Completion: 2025-05-15
• Status Verified: 2025-07
• Last Update Submitted: 2025-07-21
• Last Update Posted: 2025-07-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 48

Inclusion Criteria

• Age ranges from 18 to 40 years
• Body mass index ≥25kg/m2.
• Pregnant females in third trimester diagnosed with myalgia paraesthetica.
• Multigravida pregnant females
• Patients will be screened through Prone Knee Bend (PKB) test for femoral nerve compression.
• Positive pelvic compression test(1)

Exclusion Criteria

• Those having other entrapment syndromes or radicular symptoms
• Motor weakness
• Having a history or ongoing cancerous proliferation
• Active infection

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
quality of life is assessed by QOL questioner	at base line pre intervention, at the end of 4th week post intervention	EQ-5D is used to measure quality of life
Knee range of motion is used to measure ROM	at base line pre intervention, at the end of 4th week post intervention	measured by goniometer
neuropathic pain	at base line pre intervention, at the end of 4th week post intervention	The Neuropathic Pain Scale (NPS) is a tool used to assess the specific qualities of pain associated with neuropathic pain. It helps differentiate neuropathic pain from other types of pain by evaluating different pain sensations and their intensity. The NPS consists of 10 items, each rated on a scale of 0 to 10, where 0 is "no pain" and 10 is the "worst imaginable pain".

Trial Locations

Locations (2)

Ghurkhi Hospital; 🇵🇰 Lahore, Punjab, Pakistan

Ghurki Hospital; 🇵🇰 Lahore, Punjab, Pakistan